Comprehensive analysis of biomarkers for prostate cancer based on ...

An Improved Prostate Cancer Biomarker Test May Help Men Avoid ...

Researchers funded by NCI have developed and validated a new prostate cancer urinary biomarker test that can help differentiate who should proceed for biopsy.

Biomarkers & Genomic Testing - ZERO Prostate Cancer

Biomarker testing in prostate cancer looks at how certain sets of genes in the tumor interact and function. It can be performed on both biopsy tissue and on ...

Marker Ki-67 is a potential biomarker for the diagnosis and ...

Marker Ki-67 is a potential biomarker for the diagnosis and prognosis of prostate cancer based on two cohorts.

Identification of prostate cancer biomarkers in urinary exosomes

The green bar indicate indicate fold-enrichment for the urinary total exosomal proteome discovered in this analysis compared to the complete ...

Diagnostic Accuracy of Liquid Biomarkers for Clinically Significant ...

Many liquid biomarkers have entered clinical practice with the praise to improve the detection of clinically significant prostate cancer (csPCa) ...

a database of manually curated biomarkers for Prostate Cancer

Elevated levels of PSA are also associated with benign prostate conditions like Benign Prostatic Hyperplasia (BPH), Prostatic Intraepithelial ...

Gene Expression Profiling and Protein Biomarkers for Prostate Cancer

The Gleason score is a scoring system used to categorize a prostate cancer biopsy based on risk assessment. Tissue-based gene expression classifiers (GEC) are ...

Integrated Analysis of Multiple Biomarkers from Circulating Tumor ...

This was a prospective biomarker study evaluating expression of AR protein and splice variant expression in CTCs from patients with CRPC receiving systemic ...

A Database of Manually Curated Biomarkers for Prostate Cancer

The most common test for the diagnosis and prognosis of PCa is measurement of prostate specific antigen (PSA) (Atan and Guzel, 2013). PSA is present both in ...

A Machine Learning Method for Predicting Biomarkers Associated ...

Prostate cancer (PCa), the leading cause of cancer-related death in Western countries, predominantly affects men between the ages of 40 and 60 [1, 2]. Early ...

Active Surveillance in Prostate Cancer: Current and Potentially ...

Summary: This review article addresses the characteristics of the current and emerging PCa prognostic biomarkers, including tests available for ...

Identification of biomarkers for immunotherapy response in prostate ...

To sustain progress towards more effective immunotherapy for prostate cancer, comprehensive analyses of the genetic characteristics of the ...

Emerging biomarkers of prostate cancer (Review)

The most established and widely recognized serum biomarker for prostate cancer is total prostate-specific antigen (tPSA). PSA is a serine ...

Diagnostic and prognostic biomarkers of common urological ...

To determine whether our methylation model could distinguish lymphatic metastases, we applied the model to a prostate cancer dataset GSE73549.

Systemic inflammatory biomarkers as predictive and prognostic ...

Advances in therapy of metastatic castration-refractory prostate cancer (mCRPC) resulted in more therapeutic options and led to a higher ...

A comprehensive analysis of ncRNA-mediated interactions reveals ...

A survival model containing 8 hub genes was constructed with AUC 0.972 at 10 years, indicating that it was a specific biomarker for cancer prognosis.

Five-gene signature associating with Gleason score serve as novel ...

The differential expression of the 5 signature genes in primary prostate cancer and metastatic prostate cancer tissues was analyzed using the GSE32269 dataset [ ...

Unveiling the Roles of EGFR, GLUT1, MUC1, MRP1, P16, PD-L1 ...

This comprehensive review provided an overview of biomarkers in vulvar cancer, focusing on the significance of EGFR, GLUT1, MUC1, MRP1, P16, PD-L1, and P53.

Biomarkers Compendium - NCCN

The NCCN Biomarkers Compendium contains information designed to support decision-making around the use of biomarker testing in patients with cancer.

Comprehensive analysis of prognostic biomarkers in lung ...

Through KEGG pathway analysis, we detected a number of cancer-related pathways, including the p53 signaling pathway, the PI3K-Akt signaling pathway, and ...